<DOC>
	<DOCNO>NCT02671071</DOCNO>
	<brief_summary>The primary objective study describe socio-demographic , clinical pathological , quality life treatment characteristic patient diagnose CC Brazil .</brief_summary>
	<brief_title>Prospective Evaluation Patients With Uterine Cervical Cancer Brazilian Health Institutions - The EVITA I Study</brief_title>
	<detailed_description>The primary objective study describe socio-demographic , clinical pathological , quality life treatment characteristic patient diagnose cervix cancer ( CC ) Brazil . Other specific objective : - To describe socio-demographic characteristic : age diagnosis , education , family income , race , occupation , personal health habit - e.g.oral contraceptive use ever/never duration ; smoke never/ever/current/duration , ever drink ) , sexual history , insurance coverage ( private , public ) , institution ( private , public , philanthropic ) , obstetric history , comorbidities , performance status , human papillomavirus vaccination - To describe screen CC : access , type , frequency result . - To describe clinical pathological characteristic CC : histology ( adeno x squamous x adenosquamous x neuroendocrine x ) , International Federation Gynecology Obstetrics ( FIGO ) stage , pathological stage , exams stag , date diagnosis , site metastasis . - To describe treatment characteristic CC : date surgery , type surgery ; date duration radiotherapy , type radiotherapy ; date , type line systemic therapy ( chemotherapy , monoclonal antibody ) , - To describe treatment safety ( grade 3-4 AEs , death due treatment toxicity , discontinuation due AE ) . In addition adverse event special interest describe ( detail Safety section ) . - To describe outcome : follow-up exam date visit , persistent disease , recurrence , progression time metastatic disease , complication ( e.g . hydronephrosis/nephrostomy/ GI perforation GI &amp; genitourinary fistula . ) , death due CC death cause .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Histologic confirm invasive cervical cancer Diagnosis FIGO stag Stage 1B 2A high risk 2B4B recurrent disease Patients â‰¥18 year old 1 . Noninvasive uterine carcinoma ; 2 . Pregnancy ; 3. synchronous tumor second primary tumor past 5 year ( except thyreoid ancer nonmelanoma skin cancer ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Cervix Cancer</keyword>
</DOC>